1
>1
1
1
1
9
2
10.65 (dd, J 196, JC,H 15, C-7), 126.67 (d, J 190, C-9),
9-(ꢀ-D-Ribofuranosyl)-2-(3,5-diformyl-4-methyl-1,4-dihydro-
C,H
C,H
>
1
1
>1
27.57 (dd, JC,H 13 and 2, C-9a), 133.90 (dd, J 188, JC,H
1-pyridyl)purine (5). 1,1,3,3-Tetramethoxypropane (3.74 g, 17
mmol) was hydrolysed with HCl (50 mL, 0.1 M) and the pH
was adjusted to 4.5. Chloroacetaldehyde diethyl acetal (0.75 g,
5.0 mmol) was added and the mixture stirred for 10 min. The
pH was adjusted again to 4.5. The starting material (1.0 g, 3.7
mmol) was dissolved in 35 mL of water. The solution was
added to the first made mixture of hydrolysed 1,1,3,3-
tetramethoxypropane and chloroacetaldehyde diethyl acetal
and the pH was adjusted to 4.5. The reaction mixture was
stirred at 37 ЊC for 45 h. The reaction was stopped and the
reaction mixture was filtered. The filtrate was evaporated and
C,H
>
1
1
, C-6), 146.51 (ddd, JC,H14; 7 and 4, C-4a), 148.68 (dd, J
14, JC,H 4, C-2), 149.72 (m, JC,H 7; 4 and 2, C-3a). δ (50.69
MHz; DMSO) Ϫ216 (N-3), Ϫ191 (N-8), Ϫ161 (N-4), Ϫ155 (N-
), Ϫ142 (N-1). The signals appear as broad triplets/quartets
C,H
>1
>1
N
a
5
(
JH,H ± 0.3 Hz).
3
-(ꢀ-D-Ribofuranosyl)-5-methylimidazo-[1,2a]purine (3). 2-
Chloropropanal (8.5 mL, 12 mmol) was added to the solution
of 1 (1.0 g, 3.7 mmol) in 0.5 M KH PO (25 mL, pH 4.5) buffer
and ethanol (10 mL). The reaction was allowed to proceed at
7 ЊC for 29 h. The pH was adjusted to 4.5. The reaction was
stopped and the mixture was neutralised with aqueous
NaHCO . The mixture was filtered and the product was
isolated from the solid by preparative reversed phase chromato-
graphy. The fractions containing the product were combined
and evaporated. The oily product was crystallised from dry
ethanol at ϩ8 ЊC to give 3 (195 mg, 17%) as a crystalline light
2
4
methanol added. The product crystallised to give (247 mg, 16%)
3
3
5
as orange crystals. λ (H O)/nm 235, 287, 313 and 369 (ε/dm
max 2
Ϫ1 Ϫ1
mol cm 17600, 16900, 22900 and 5860); λ (H O)/nm 213,
min
2
3
3
Ϫ1
Ϫ1
2
5
2
62, 294 and 349 (ε/dm mol cm 12000, 7780, 15700 and
170); m/z (EI): 401.1337 (M , C H N O requires 401.1335),
ϩ
18
19
5
6
54 (100%), 269 (7). δ (500.16 MHz; DMSO) 1.04 (3 H, d,
H
a
JCH3,4Љ 6.7, – CH ), 3.66 (1 H, d, H-4Љ), 3.67 (1 H, dd , J
Ϫ12.2, H-5Јb), 3.74 (1 H, dd , H-5aЈ), 4.04 (1 H, dd , J
J4Ј,5Јb 3.4, H-4Ј), 4.29 (1 H, dd , J 3.8, H-3Ј), 4.67 (1 H, dd ,
J2Ј,3Ј 5.0, H-2Ј), 6.10 (1 H, dd , J 5.4, H-1Ј), 8.55 (2 H, s, H-
3
5Јb,5Јa
a
a
3.8,
3
Ϫ1
4Ј,5Јa
yellow powder. λ (H O)/nm 231, 296 and 343 (ε/dm mol
max
2
a
a
Ϫ1
3
3Ј,4Ј
cm 35600, 6530 and 2880); λ (H O)/nm 265 and 320 (ε/dm
min
2
a
Ϫ1
Ϫ1
ϩ
1Ј,2Ј
mol
cm
1890 and 2500); m/z (EI) 305.1128 (M ,
2
9
1
1
8
Љ), 8.81 (1 H, s, H-8), 9.08 (1 H, s, H-6), 9.56 (1 H, s, H-5Љ) and
C H N O requires 305.1124), 173 (100%). δ (500.16 MHz;
13
15
5
4
H
1
.57 (1H, s, H-5Љ). δ (125.78 MHz; DMSO) 21.14 (dd, J
a
C
C,H
DMSO) 2.51 (3 H, JCH3,6 0.3, s, – CH ), 3.59 (1 H,ddd , J
3
5Јb, 5Јa
>1
1
1
28, JC,H 6, -CH ), 22.65 (dm, J 133, C-4Љ), 61.07 (t, J
a
3
C,H
C,H
Ϫ12.0, J5
Јb,5Ј-OH
5.8, H-5Јb), 3.71 (1 H, ddd , J
5.1, H-5Јa),
5Јa,5Ј-OH
a
1
1
42, C-5Ј), 70.07 (d, J 148, C-3Ј), 73.70 (d, J 150, C-2Ј),
5.70 (d, J 150, C-4Ј), 87.48 (d, J 166, C-1Ј), 125.17 (2C,
a
C,H
C,H
3
3
.98 (1 H, ddd , J4
4.00, J4Ј,5Јb 4.2, H-4Ј), 4.21 (1 H, ddd , J
Ј,5Јa 3Ј,4Ј
a
1
1
C,H
C,H
.7, J3
Ј,3Ј-OH
5.1, H-3Ј), 4.64 (1 H, ddd , J
H-2Ј), 5.10 (1 H, t, 5Ј-OH), 5.22 (1 H, d, 3Ј-OH), 5.56 (1 H, d,
Ј-OH), 5.98 (1 H, d, J1Ј,2Ј 5.6, H-1Ј), 7.44 (1 H, d, J6,CH3 0.3, H-
), 8.76 (1 H, s, H-2), 9.29 (1 H, s, H-9). δ (125.78 MHz;
2Ј,3Ј
4.7, J2Ј,2Ј-OH 5.9,
>1
>1
dm, JC,H 26, C-3Љ), 132.05 (dd, JC,H 12 and 6, C-5), 140.76
1
>1
1
and 140.81 (2C, dm, J 184,1 JC,H 5, C-2Љ), 145.60 (dd, J
C,H
C,H
2
6
>1
>1
2
1
1
16, JC,H 4, C-8), 149.02 (d, J 186, C-6), 150.07 (dt, JC,H
C,H
C
>1
2 and 3, C-2), 152.18 (ddd, JC,H 8; 3 and 3, C-4), 190.87 and
90.92 (2C, dt, JC,H 176, JC,H 7, C-5Љ). δ (50.69 MHz;
1
1
DMSO) 8.89 (q, J
129,-CH ), 61.23 (t, J
140, C-5Ј),
C,H
3
C,H
1
>1
1
1
N
7
0.20 (d, J
149, C-3Ј), 73.11 (d, J
148, C-2Ј), 85.30 (d,
C,H
>1
C,H
DMSO) Ϫ236 (N-1Љ), Ϫ208 (N-3), Ϫ164 (N-4), Ϫ136 (N-6),
1
1
JC,H 149, C-4Ј), 87.14 (d, J
4; 14 and 7, C-7), 124.27 (d, J 189, C-9), 127.37 (d, JC,H
2, C-9a), 131.44 (ddd, J
164, C-1Ј), 117.68 (ddd, JC,H
C,H
1
a
Ϫ135 (N-1). The signals appear as broad triplets/quartets (J
>1
H,H
1
1
(
1
(
C,H
>1
±
0.3 Hz).
1
186,
J
9 and 4, C-6), 146.07
C,H
C,H
1
>1
>1
dd, JC,H 13 and 4, C-4a), 148.38 (dd, J 214, JC,H 4, C-2),
C,H
>
1
48.83 (dd, JC,H 8 and 6, C-3a). δ (50.69 MHz; DMSO) Ϫ217
N
Acknowledgements
a
N-3), Ϫ190 (N-8), Ϫ161 (N-4), Ϫ156 (N-5), Ϫ141 (N-1). The
We are grateful to Mr Markku Reunanen for recording the
mass spectra. Financial support from the Finnish Graduate
School of Bioorganic and Medicinal Chemistry is gratefully
acknowledged (P. Virta). The work of Peter Mattjus was sup-
ported by the Academy of Finland, Sigrid Jusélius Foundation,
Magnus Ehrnrooth Foundation, Svenska Kulturfonden,
Medicinska understödsföreningen Liv och Hälsa r.f. and Åbo
Akademi.
signals appear as broad triplets/quartets (JH,H ± 0.3 Hz).
3
-(ꢀ-D-Ribofuranosyl)-5-formylimidazo-[1,2a]purine
Bromomalonaldehyde (1.7 g, 11 mmol) was added to the solu-
tion of 1 (0.78 g, 3.0 mmol) in 0.5 M KH PO (35 ml, pH 4.5)
(4).
2
4
buffer and ethanol (15 mL). The reaction was allowed to
proceed at 37 ЊC for 28 h and the pH was adjusted to 4.5. The
reaction was stopped and the mixture was filtered. The product
was isolated from the solid by preparative reversed phase
chromatography. Methanol was added to the syrup and evapor-
References
ated. The product was crystallised from ethanol (185 mg, 20%)
3
as yellow crystalline 4. λ (H O)/nm 214, 277 and 313 (ε/dm
max
2
1 (a) J. R. Barrio, J. A. Secrist III and N. J. Leonard, Biochem. Biophys.
Res. Commun., 1972, 46(2), 597–604; (b) P. D. Sattsangi, N. J.
Leonard and C. R. Frihart, J. Org. Chem., 1977, 42(20), 3292–3296;
Ϫ1
Ϫ1
mol cm3 15900, 35300 and 10600); λ (H O)/nm 233 and
min
2
Ϫ1
Ϫ1
ϩ
2
92 (ε/dm mol cm 5650 and 7120); m/z (EI) 319.0913 (M ,
(
c) R. Khazanchi, P-L. Yu and F. Johnson, J. Org. Chem., 1993, 58
C H N O requires 319.0916), 187 (100%). δ (500.16 MHz;
1
3
13
5
5
H
a
(9), 2552–2556; (d ) J. T. Kusmierek, D. E. Jensen, S. J. Spengler,
R. Stolarski and B. Singer, J. Org. Chem., 1987, 52(12), 2374–2378;
(
DMSO) 3.61 (1 H, dd , J
H, dd , J5
Јa,5-OH
Ј), 4.22 (1 H, dd , J3
Ϫ12.0, J
5.0, H-5Јb), 3.73 (1
3.7, J4Ј5Јb 3.7, H-
4.3, J3Ј,3Ј-OH 5.2, H-3Ј), 4.62 (1 H, dd ,
5Јb,5Јa
5Јb,5-OH
a
a
4.8, H-5Јa), 4.01 (1 H, dd , J
4Ј,5Јa
e) S. Mikkola, N. Koissi, K. Ketomäki, S. Rauvala, K. Neuvonen
a
a
4
Ј,4Ј
and H. Lönnberg, Eur. J. Org. Chem., 2000, 12, 2315–2323; ( f ) S. C.
Srivastava, S. K. Raza and R. Misra, Nucleic Acid Res., 1994, 22,
1296–1304.
J2Ј,3Ј 3.7, J2Ј,2Ј-OH 5.7, H-2Ј), 5.11 (1 H, s, 5Ј-OH), 5.26 (1 H, s,
Ј-OH), 5.60 (1 H, s, 2Ј-OH), 6.07 (1 H, d, J1Ј,2Ј 5.2, H-1Ј), 8.67
1 H, s, H-6), 9.00 (1 H, s, H-2), 9.89 (1 H, s, CHO), 10.10 (1 H,
3
2
3
(a) N. Hamamichi and T. Miyasaka, J. Org. Chem., 1994, 59, 1525–
(
1
1531; (b) G. A. Panday and M. Moriya, Biochemistry, 1996, 35,
s, H-9). δ (125.78 MHz; DMSO) 60.98 (t, J 140, C-5Ј), 70.03
C
C,H
1
1487–11492.
1
1
1
(
d, J
150, C-3Ј), 73.64 (d, J
148, C-2Ј), 85.48 (d, J
C,H C,H
>1
C,H
J. A. Secrist, J. R. Barrio, N. J. Leonard and G. Weber, Biochemistry,
1972, 11(19), 3499–3506.
1
1
1
48, C-4Ј), 87.44 (d, J 166, C-1Ј), 122.46 (dd, JC,H 31 and
C,H
1 >1
5, C-7), 127.90 (d, J 193, C-9), 129.03 (dd, JC,H1 12 and 2,
4 M. Hawkins, W. Pfleiderer, A. Mazumder, Y. Pommier and F. Balis,
Nucleic Acids Res., 1995, 23, 2872–2880.
5 (a) S. L. Driscoll, M. E. Hawkins, F. M. Balis, W. Pfleiderer and
W. R. Laws, Biophys. J., 1997, 73, 3277–3286; (b) I. Zagórowska and
R. W. Adamiak, Biochimie, 1996, 78, 123–130; (c) J. Fujimoto,
Z. Nuesca, M. Mazurek and L. C. Sowers, Nucleic Acids Res., 1996,
C,H
1
C-9a), 148.77 (dm, JC,H 189, C-6), 149.46 (dd, JC,H 216,
>
>
1
1
>1
JC,H4, C-2), 150.20 (dd, JC,H 15 and 5, C-4a), 151.14 (ddd,
JC,H 6; 5 and 3, C-3a), 178.13 (d, JC,H 178, CHO). δ (50.69
1
N
MHz; DMSO) Ϫ211 (N-3), Ϫ195 (N-8), Ϫ158 (N-4), Ϫ141
a
(
N-5), Ϫ139 (N-1). The signals appear as broad triplets/
2
4(4), 754–759; (d ) B. Holz, S. Klimasauskas, S. Serva and
quartets (JH,H ± 0.3 Hz).
E. Weinhold, Nucleic Acids Res., 1998, 26(4), 1076–1083.
8
26
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2, 8 2 1 – 8 2 7